Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency

被引：0
|
作者：
Pier Giorgio Cojutti
Ezio Zanon
Samantha Pasca
Federico Pea
机构：
[1] IRCCS Azienda Ospedaliero Universitaria di Bologna,SSD Clinical Pharmacology
[2] University of Bologna,Department of Medical and Surgical Sciences, Alma Mater Studiorum
[3] Padova University Hospital,Department of Medicine, DIMED, Thrombotic and Haemorrhagic and Coagulation Diseases Unit, Veneto Regional Centre for Haemophilia and Thrombophilia
来源：
Clinical Pharmacokinetics | 2022年 / 61卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：505 / 513
页数：8
相关论文
共 42 条
  • [1] Real-Life Population Pharmacokinetics of Recombinant Factor XIII and Dosing Considerations for Preventing the Risk of Bleeding in Patients with FXIII Congenital Deficiency
    Cojutti, Pier Giorgio
    Zanon, Ezio
    Pasca, Samantha
    Pea, Federico
    CLINICAL PHARMACOKINETICS, 2022, 61 (04) : 505 - 513
  • [2] Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients
    Williams, M.
    Will, A.
    Stenmo, C.
    Rosholm, A.
    Tehranchi, R.
    HAEMOPHILIA, 2014, 20 (01) : 99 - 105
  • [3] Safety and pharmacokinetics of recombinant factor XIII in patients with Congenital Factor XIII deficiency.
    Lovejoy, AE
    Reynolds, TC
    Butine, MD
    Visich, JE
    Ishak, LM
    Belvedere, MA
    Nugent, DJ
    BLOOD, 2003, 102 (11) : 307A - 307A
  • [4] Safety and pharmacokinetics of recombinant factor XIII-A2 administration in patients with congenital factor XIII deficiency
    Lovejoy, AE
    Reynolds, TC
    Visich, JE
    Butine, MD
    Young, G
    Belvedere, MA
    Blain, RC
    Pederson, SM
    Ishak, LM
    Nugent, DJ
    BLOOD, 2006, 108 (01) : 57 - 62
  • [5] Pharmacokinetics of recombinant factor XIII at steady state in patients with congenital factor XIII A-subunit deficiency
    Kerlin, B.
    Brand, B.
    Inbal, A.
    Halimeh, S.
    Nugent, D.
    Lundblad, M.
    Tehranchi, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (12) : 2038 - 2043
  • [6] Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures
    Janbain, Maissaa
    Nugent, Diane J.
    Powell, Jerry S.
    St-Louis, Jean
    Frame, Virginia B.
    Leissinger, Cindy A.
    TRANSFUSION, 2015, 55 (01) : 45 - 50
  • [7] Pharmacokinetics of recombinant FXIII at steady-state in patients with congenital FXIII A-subunit deficiency
    Kerlin, B.
    Brand, B.
    Inbal, A.
    Halimeh, S.
    Nugent, D.
    Lundblad, M.
    Tehranchi, R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 235 - 236
  • [8] Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency
    Brand-Staufer, B.
    Carcao, M.
    Kerlin, B. A.
    Will, A.
    Williams, M.
    Tornoe, C. W.
    Lundblad, M. Sandberg
    Nugent, D.
    HAEMOPHILIA, 2015, 21 (03) : 380 - 385
  • [9] Safety and Efficacy of Recombinant Factor XIII (FXIII) in Patients with Congenital FXIII A-Subunit Deficiency, Results from the Mentor™2 Trial
    Carcao, Manuel
    Altisent, Carmen
    Castaman, Giancarlo
    Fukutake, Katsuyuki
    Inbal, Aida
    Kerlin, Bryce A.
    Kessler, Craig M.
    Lassila, Riitta
    Oldenburg, Johannes
    Rosholm, Anders
    Garly, May-Lill
    Nugent, Diane J.
    BLOOD, 2016, 128 (22)
  • [10] Comparison of pharmacokinetics of recombinant Factor XIII between children and adults with congenital Factor XIII deficiency
    Tehranchi, R.
    Stenmo, C.
    Rosholm, A.
    Williams, M.
    HAEMOPHILIA, 2012, 18 (05) : 831 - 832
12345